ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR628/001/SRR6288041/SRR6288041_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR628/000/SRR6288040/SRR6288040_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR628/002/SRR6288042/SRR6288042_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR628/000/SRR6288040/SRR6288040_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR628/001/SRR6288041/SRR6288041_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR628/002/SRR6288042/SRR6288042_2.fastq.gzprimaryOK200GenomicsMedBiotech laboratory, faculty of medicine and pharmacy, rabat/ Mohamed V university rabathttps://www.ebi.ac.uk/ena/browser/view/PRJNA418286we performed the exome sequencing to three moroccan patients affected by Multiple Sclerosis using the illumina MiSeq platform/trusightOne Kit , to identify specific variants to moroccan population compared to the reference genome.ENAfalseexome sequencing of moroccan patients with multiple sclerosis2023-05-192017-11-16PRJNA418286